Gil-Longo J, de los Reyes Laguna M, Verde I, Castro M E, Orallo F, Fontenla J A, Calleja J M, Ravina E, Teran C
Department of Pharmacology, University of Santiago de Compostela, Spain.
J Pharm Sci. 1993 Mar;82(3):286-90. doi: 10.1002/jps.2600820314.
3-Hydrazinocycloheptyl[1,2-c]pyridazine (4) and its hydrazone derivatives 3-[N1-(isopropylidene)]hydrazinocycloheptyl[1,2-c]pyridazine [correction of hydrazinocyclohexyl] (5) and 3-[N1-(isobutylidene)]hydrazinocycloheptyl[1,2-c]pyridazine (6) were prepared, and their activity against genetic, neurogenically-induced, and deoxycorticosterone acetate -NaCl-induced hypertension was found to be at least as great as that of hydralazine. The results of studying vasorelaxation of rat aorta by 4 and hydralazine suggest that both these compounds owe their antihypertensive activity to direct relaxation of vascular smooth muscle.